Synthesis and Reaction of 1,5,3,7-Diazadiphosphocine-1,5-Dicarboxylic Acids

국문 초록 (Abstract)

본 연구는 MRI 조영제나 새로운 생리활성 물질을 개발키 위해 paraformaldehyde와 hypophosphorous acid를 아미노산인 glycine 혹은 glutamic acid와 함께 반응시켜 3,7-dihydroxy-3,7-dioxoperhydro-1,5,3,7-diazadiphos-phocme-1,5-diacetic acid 1 와 3,7-dihydrexy-3,7-dioxoperhydre-1,5,3,7-diazadiphos-phocme-1,5-di- (2-glutaric acid)3을 합성하였다. 그러나 aspartic acid에 의한 2-[5-(1,2-dicarboxy-ethyl)-3,7-dihydroxy-3,7-dioxo-315.715-[1,5,3,7]diazadiphosphocan-1-yl]-succinic acid 2는 얻지 못했다. 합성 된 3,7-dihydroxy-3,7-dioxoperhydro-1,5,3,7-dia-zadiphosphocine-1,5-diacetic acid 1을 산 촉매에 의한 에스테르화반응시켜 화합물 3,7-dihydroxy-3,7-dioxoper-hydro-1,5,3,7-diazadiphosphocine-1,5-diacetic acid methyl ester 4, 3,7-dihydroxy-3,7-dioxoperhydro-1,5,3,7-dia-zadiphosphocine-1,5-diacetic acid ethyl ester 5, 그리고 3,7-dihyoxy-3,74dioxoperhyo-1,5,3,7-diazadiphosphocine-1,5-diacetic acid propyl ester 6을 합성하였다. 계속해서 다양한 반응을 통해 새로운 화합물을 합성할 것이며 생리활성검색도 실시할 예정이다.

다국어 초록 (Multilingual Abstract)

In order to synthesize new bioactive compounds and contrasting agents, reactions of glycine and glutamic acid as an animo acid with paraformaldehyde and hypophosphorous acid were executed. Products are 3,7-dihydroxy-3,7-dioxoperhydro-1,5,3,7-diazadiphosphocine-1,5-diacetic acid 1 and 3,7-dihydroxy-3,7- dioxoperhydre-1,5,3,7-diazadiphosphocine-1,5-di-(2-glu taric acid) 3. 2-[5-(1,2-Dicarboxyethyl)-3,7-dihydroxy-3,7-dioxo-315.715-[1,5,3,7] diazadiphosphocan-1-yl]-succinic acid 2 by using aspartic acid was not obtained. Esterification of 3,7- dihydroxy-3,7-dioxoperkydro-1,5,3,7-diaza-diphosphocine-1,5-diacetic acid 1 by treatment of methanol, ethanol, and propanol were executed. 3,7-Dihydroxy-3,7-dioxoperhydro-1,5,3,7-diazadiphosphocine-1,5-diacetic acid methyl ester 4, 3.7-dihydroxy-3,7-dioxoperhydro-1,5,3,f-diazadiphosphocine-1.5-diacetic acid ethyl ester 5, and 3,7-dihydroxy-3,7-dioxoperhydro-1,5,3,7-diazadiphosphocine-1,5-diacetic acid propyl ester 6 were respectively synthesized in good yields. Continuously, we will try synthesis of novel compounds and evaluation of biological activity.

참고문헌 (Reference)

1 Tatchell, A. R., "Vogel's Textbook of Practical Organic Chemistry, 4th eds." The Chaucer Press 264-319, 1978

2 Bodern, N. R., "The design and synthesis of simple molecular tethers for binding biomembranes to a gold surface" 53 : 10939-10952, 1997

3 Lattuada, L, "Synthesis of Gd-DTPA- cholesterol: a new lipophilic gadolinium complex as a potential MRI contrast agent" 44 : 3893-3895, 2003

4 Vu, H., "Synthesis and Properties of Cholesteryl-Modified Triple-Helix Forming Oligonucleotides Containing a Triglycyl Linker" 5 : 666-668, 1994

5 Arnold, P., "Superparamagnetic iron oxide (SPIO) enhancement in the cirrhotic liver: a comparison of two doses of ferumoxides in patients with advanced disease" 21 : 695-700, 2003

6 Akiyoshi, K., "Stabilization of Insulin upon Supramolecular Complexation with Hydrophobized Polysaccharide Nanoparticle" 8 : 707-708, 1995

7 Lauffer, R. B., "Preparation and water relaxation properties of proteins labeled with paramagnetic metal chelates" 3 : 11-16, 1985

8 Ladd, D. L., "Polymeric Gadolinium Chelate Magnetic Resonance Imaging Contrast Agents: Design, Synthesis and Properties" 10 : 361-370, 1999

9 Thunus, L., "Overview of transition metal and lanthanide complexes as diagnostic tools" 184 : 125-155, 1999

10 Aime, S., "One-step synthesis of a new eight-membered cyclic ligand from glycine, formaldehyde and hypophosphorous acid" 43 : 8387-8389, 2002

11 Albrecht, S., "Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages" 36 : 976-984, 2004

12 Tatsuhirom, Y., "In vivo MR detection of vascular endothelial injury using a new class of MRI contrast agent. Bioorg" 14 : 2787-2790, 2004

13 Tournier, H., "Gadolinium-Containing Mixed Micelle Formulations: A New Class of Blood Pool MRI/MRA Contrast Agents" 9 : S20-S28, 2002

14 Reichert, D. E., "Anderson. Metal complexes as diagnostic tools" 184 : 3-66, 1999

15 Schmiedl, U., "Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies" 162 : 205-210, 1987